ClinicalTrials.gg
RecruitingNCT06763419Updated Jan 8, 2025

Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement

An interventional study of External low level laser therapy and Internal low level laser therapy in Temporomandibular Joint Disorders, sponsored by Nourhan M.Aly. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-01-08.

Sponsored by Nourhan M.Aly · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 63 studies in Temporomandibular Joint Disorders with a site in Egypt — 10 open to participants now, 14 under way, none of them phase 3. Temporomandibular Joint Disorders · Egypt.

Planned enrollment
10th of 49
50 · median 30
Started
2024
with 9 others
No phase
42 of 63
9 open now
Primary completion
2025-02
later than 2 of 13 live
Registered
38th of 63
by date
Lead sponsor
2 of 63
Nourhan M.Aly

Among the 63 studies in Temporomandibular Joint Disorders with a site in Egypt, this one is the 10th largest by planned enrollment of the 49 interventional ones that give a count, is one of 10 that started in 2024, is one of 42 with no phase, reaches primary completion later than 2 of the 13 other live ones, and was the 38th registered.

Temporomandibular Joint Disorders

593 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

Browse Temporomandibular Joint Disorders studies →

Open to participants now

10 of the 63 studies in Temporomandibular Joint Disorders with a site in Egypt are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 76 Temporomandibular Joint Disorders studies recruiting now, 26 (34%) set no upper age limit and 46 (61%) stop at 75 or younger; 7 take children under 18; 23 take healthy volunteers.

This study: 20 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 63 studies in Temporomandibular Joint Disorders with a site in Egypt, or all of them as a file.
02

Study summary

Aim of the study was to compare the efficacy of internal versus external photobiomodulation (PBM) in the management of patients with TMJ internal derangements (TMJ-ID).

03

Conditions studied

  • Temporomandibular Joint Disorders
04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Painful click at temporomandibular joint (TMJ) area.
  • Pain at the lateral pterygoid muscle.
  • Presence of full or nearly full complement of natural teeth with acceptable occlusion

Exclusion criteria

Exclusion Criteria:

  • Patients who have radiographic evidence of degenerative conditions of TMJ.
  • Patients under current dental or physical therapy that could affect TMD.
  • History of recent trauma.
  • The presence of systemic diseases (i.e. rheumatoid arthritis, osteoarthritis).
  • Pregnant and lactating females.
  • Presence of open bite.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    External low level laser therapy

    Device: External low level laser therapy

  • Active comparator
    Internal low level laser therapy

    Device: Internal low level laser therapy

Interventions

  • DeviceExternal low level laser therapy

    Patients received 8 sessions of external diode laser (635 nm).

  • DeviceInternal low level laser therapy

    Patients received 8 diode laser (635 nm) sessions applied internally

06

What researchers measure

Primary outcomes

  1. Pain level assessment using Visual Analogue Scale

    All patients will be evaluated subjectively through Visual Analogue Scale (VAS) to clinically assess the pain intensity with ratings between 0 for pain-free and 10 for maximum pain

    Time frame: after one month from the last laser session

  2. Oral health-related quality of life using OHIP-TMD

    Oral health-related quality of life will be assessed using OHIP-TMD, a 22-item temporomandibular disorder-specific version of the Oral Health Impact Profile (OHIP). Each item in the OHIP-TMDs is scored on a Likert scale, often ranging from: 0 (Never) to 4 (Very often). For each respondent, the scores for all 22 items are summed to create a total score. The total score ranges from 0 to 88, where higher scores indicate a greater negative impact on oral health-related quality of life.

    Time frame: after one month from the last laser session

  3. Maximum mouth opening evaluation using the Miller index

    The Miller Index is calculated as a ratio of the observed maximum interincisal distance (distance between the edges of the upper and lower incisors when the mouth is fully open) to the patient's height. This provides a normalized measure of mouth opening relative to body stature. Miller Index= Maximum Interincisal Distance (mm)/Height (cm) Normal Range: A typical Miller Index is around 1.6 to 1.7 mm/cm in healthy individuals. This means that for every centimeter of height, the expected mouth opening is about 1.6 to 1.7 mm. Deviations: * Lower than Normal: May indicate restricted mouth opening (e.g., trismus, TMDs, fibrosis, ankylosis). * Higher than Normal: May occur in conditions involving hypermobility.

    Time frame: after one month from the last laser session

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Feb 2025, 2 months after the start.

Of 244 non-industry interventional studies with no phase under Temporomandibular Joint Disorders, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's planned 2 months is below that.

Counting every sponsor, half of 248 studies reached it within 11 months; a quarter within 5 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2024
First posted
Jan 8, 2025
StartActual
Dec 25, 2024
Primary completionEst.
Feb 28, 2025
CompletionEst.
Feb 28, 2025
Last update
Jan 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06763419
Lead sponsor
Nourhan M.Aly
Responsible party
Nourhan M.Aly (Assistant Lecturer of Dental Public Health, University of Alexandria) — Sponsor-investigator
First posted
Jan 8, 2025
Start date
Dec 25, 2024
Primary completion
Feb 28, 2025 (estimated)
Completion
Feb 28, 2025 (estimated)
Last update
Jan 8, 2025

Study contacts

Mariam Bahgat, PhD
Contact
mariam.amin@alexu.edu.eg
+20 12 22882107
Nermeen Rady, PhD
principal investigator · Faculty of Dentistry, Alexandria University, Egypt
Mariam M Bahgat, PhD
study chair · Faculty of Dentistry, Alexandria University, Egypt
Aly Atteya, PhD
principal investigator · Faculty of Dentistry, Alexandria University, Egypt
Hoda MA Abdel-Naby, PhD
study director · Faculty of Medicine, Alexandria University, Egypt

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion